Automera focuses on a novel therapeutic methods to develop drugs.
Automera has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Automera's investors include Xora Innovation, EDBI, Accelerator Life Science Partners, ClavystBio.
Automera is headquartered in Singapore, Singapore.
Automera focuses on a novel therapeutic methods to develop drugs.
Automera is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Automera — Funding & Investors." VCBacked, September 26, 2023, https://www.vcbacked.co/company/automera. Accessed July 23, 2026.
VCBacked. (2023). Automera — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/automera
{{cite web |title=Automera — Funding & Investors |url=https://www.vcbacked.co/company/automera |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated